Arcadia Biosciences (RKDA) Cash from Investing Activities (2016 - 2025)
Arcadia Biosciences' Cash from Investing Activities history spans 12 years, with the latest figure at $250000.0 for Q2 2025.
- For Q2 2025, Cash from Investing Activities fell 94.62% year-over-year to $250000.0; the TTM value through Dec 2025 reached $750000.0, down 89.78%, while the annual FY2025 figure was $750000.0, 89.78% down from the prior year.
- Cash from Investing Activities reached $250000.0 in Q2 2025 per RKDA's latest filing, down from $500000.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $17.4 million in Q2 2021 to a low of -$4.7 million in Q2 2023.
- Average Cash from Investing Activities over 5 years is $1.2 million, with a median of $215000.0 recorded in 2024.
- Peak YoY movement for Cash from Investing Activities: crashed 9925.0% in 2023, then soared 12400.0% in 2025.
- A 5-year view of Cash from Investing Activities shows it stood at -$70000.0 in 2021, then soared by 501.43% to $281000.0 in 2022, then plummeted by 81.49% to $52000.0 in 2023, then surged by 4736.54% to $2.5 million in 2024, then crashed by 90.06% to $250000.0 in 2025.
- Per Business Quant, the three most recent readings for RKDA's Cash from Investing Activities are $250000.0 (Q2 2025), $500000.0 (Q1 2025), and $2.5 million (Q4 2024).